The new design is a screw-cage hybrid intended to facilitate insertion and osseointegration, according to a Jan. 23 news release. The device is self-drilling, self-tapping and compresses across the sacroiliac joint.
Sacrix added more graft space, while maintaining the product’s biomechanical and pull-out strength. An orthopedic spine surgeon developed the device with input from pain management and interventional physicians.
The company said it has performed more than 20 labs in 2020 and five labs so far in 2021.
Sacrix is a portfolio company of KICVentures Group, which acquired NanoFuse Biologics in December.
More articles on devices:
Spine surgeon, inventor files patent infringement suit against NuVasive
14 key thoughts on bundled payments in spine surgery
Flexibility, patience & financial stability — 5 spine surgeons on lessons learned in 2020
